FILGRASTIM-SNDZ for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where FILGRASTIM-SNDZ was used for Neoplasm malignant.
Most Reported Side Effects for FILGRASTIM-SNDZ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 505 | 29.5% | 501 | 8 |
| White blood cell count decreased | 79 | 4.6% | 1 | 11 |
| Hospitalisation | 68 | 4.0% | 0 | 61 |
| Neoplasm malignant | 62 | 3.6% | 23 | 2 |
| Bone pain | 61 | 3.6% | 1 | 8 |
| Pain | 39 | 2.3% | 0 | 5 |
| Malaise | 38 | 2.2% | 2 | 3 |
| Pyrexia | 38 | 2.2% | 2 | 17 |
| Fatigue | 37 | 2.2% | 2 | 4 |
| Drug ineffective | 32 | 1.9% | 3 | 4 |
| Dyspnoea | 30 | 1.8% | 1 | 10 |
| Full blood count decreased | 30 | 1.8% | 0 | 7 |
| Back pain | 29 | 1.7% | 0 | 3 |
| Illness | 28 | 1.6% | 1 | 4 |
| Nausea | 26 | 1.5% | 1 | 6 |
Other Indications for FILGRASTIM-SNDZ
Product used for unknown indication (941)
Neutropenia (113)
Agranulocytosis (55)
Breast cancer female (47)
White blood cell count decreased (24)
Chemotherapy (23)
Plasma cell myeloma (17)
Acute myeloid leukaemia (16)
Lung neoplasm malignant (13)
Pancreatic carcinoma (13)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)